BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chilamakuri R, Agarwal S. COVID-19: Characteristics and Therapeutics. Cells 2021;10:206. [PMID: 33494237 DOI: 10.3390/cells10020206] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 27.0] [Reference Citation Analysis]
Number Citing Articles
1 Zarei M, Rahimi K, Hassanzadeh K, Abdi M, Hosseini V, Fathi A, Kakaei K. From the environment to the cells: An overview on pivotal factors which affect spreading and infection in COVID-19 pandemic. Environ Res 2021;201:111555. [PMID: 34197816 DOI: 10.1016/j.envres.2021.111555] [Reference Citation Analysis]
2 Nittner-Marszalska M, Rosiek-Biegus M, Kopeć A, Pawłowicz R, Kosińska M, Łata A, Szenborn L. Pfizer-BioNTech COVID-19 Vaccine Tolerance in Allergic versus Non-Allergic Individuals. Vaccines (Basel) 2021;9:553. [PMID: 34070671 DOI: 10.3390/vaccines9060553] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Palermo E, Di Carlo D, Sgarbanti M, Hiscott J. Type I Interferons in COVID-19 Pathogenesis. Biology (Basel) 2021;10:829. [PMID: 34571706 DOI: 10.3390/biology10090829] [Reference Citation Analysis]
4 Gediz Erturk A, Sahin A, Bati Ay E, Pelit E, Bagdatli E, Kulu I, Gul M, Mesci S, Eryilmaz S, Oba Ilter S, Yildirim T. A Multidisciplinary Approach to Coronavirus Disease (COVID-19). Molecules 2021;26:3526. [PMID: 34207756 DOI: 10.3390/molecules26123526] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Muntean IA, Pintea I, Bocsan IC, Dobrican CT, Deleanu D. COVID-19 Disease Leading to Chronic Spontaneous Urticaria Exacerbation: A Romanian Retrospective Study. Healthcare (Basel) 2021;9:1144. [PMID: 34574918 DOI: 10.3390/healthcare9091144] [Reference Citation Analysis]
6 Masand VH, Sk MF, Kar P, Rastija V, Zaki MEA. Identification of Food Compounds as inhibitors of SARS-CoV-2 main protease using molecular docking and molecular dynamics simulations. Chemometr Intell Lab Syst 2021;217:104394. [PMID: 34312571 DOI: 10.1016/j.chemolab.2021.104394] [Reference Citation Analysis]
7 Abu Mouch S, Roguin A, Hellou E, Ishai A, Shoshan U, Mahamid L, Zoabi M, Aisman M, Goldschmid N, Berar Yanay N. Myocarditis following COVID-19 mRNA vaccination. Vaccine 2021;39:3790-3. [PMID: 34092429 DOI: 10.1016/j.vaccine.2021.05.087] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 22.0] [Reference Citation Analysis]
8 Heffernan E, Kennedy L, Hannan MM, Ramlaul N, Denieffe S, Courtney G, Watt A, Hurley J, Lynch M, Fitzgibbon M. Performance characteristics of five SARS-CoV-2 serological assays: Clinical utility in health-care workers. Ann Clin Biochem 2021;:45632211012728. [PMID: 33845592 DOI: 10.1177/00045632211012728] [Reference Citation Analysis]
9 Norris V, Ovádi J. Role of Multifunctional Cytoskeletal Filaments in Coronaviridae Infections: Therapeutic Opportunities for COVID-19 in a Nutshell. Cells 2021;10:1818. [PMID: 34359986 DOI: 10.3390/cells10071818] [Reference Citation Analysis]
10 Rotondo JC, Martini F, Maritati M, Mazziotta C, Di Mauro G, Lanzillotti C, Barp N, Gallerani A, Tognon M, Contini C. SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants. Viruses 2021;13:1687. [PMID: 34578269 DOI: 10.3390/v13091687] [Cited by in Crossref: 6] [Article Influence: 6.0] [Reference Citation Analysis]
11 Cheng XW, Li J, Zhang L, Hu WJ, Zong L, Xu X, Qiao JP, Zheng MJ, Jiang XW, Liang ZK, Zhou YF, Zhang N, Zhu HQ, Xu YH. Identification of SARS-CoV-2 Variants and Their Clinical Significance in Hefei, China. Front Med (Lausanne) 2021;8:784632. [PMID: 35083244 DOI: 10.3389/fmed.2021.784632] [Reference Citation Analysis]
12 Jiang Y, Zhao T, Zhou X, Xiang Y, Gutierrez‐castrellon P, Ma X. Inflammatory pathways in COVID‐19: Mechanism and therapeutic interventions. MedComm 2022;3. [DOI: 10.1002/mco2.154] [Reference Citation Analysis]
13 Sanyaolu A, Okorie C, Marinkovic A, Prakash S, Williams M, Haider N, Mangat J, Hosein Z, Balendra V, Abbasi AF, Desai P, Jain I, Utulor S, Abioye A. Current advancements and future prospects of COVID-19 vaccines and therapeutics: a narrative review. Therapeutic Advances in Vaccines and Immunotherapy 2022;10:251513552210975. [DOI: 10.1177/25151355221097559] [Reference Citation Analysis]
14 Zayour M, Soukarieh K, Al Ashkar R, Almoussawi M, Nassereldine R, Atat R, Mansour B. Acute Cerebral Ischemic Infarct in a 34-Year-Old Patient After an Asymptomatic COVID-19 Infection: A Case Report. Cureus. [DOI: 10.7759/cureus.21507] [Reference Citation Analysis]
15 Yang S, Tong Y, Chen L, Yu W. Human Identical Sequences, hyaluronan, and hymecromone ─ the new mechanism and management of COVID-19. Mol Biomed 2022;3:15. [PMID: 35593963 DOI: 10.1186/s43556-022-00077-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Stamatopoulou M, Tsamadias V, Theodosopoulos T, Demeridou S, Kaparos G, Memos N, Konstadoulakis M, Baka S. Rapid decay of anti-SARS-CoV-2 antibodies in infection-naïve healthcare workers four months after vaccination. Germs 2021;11:625-9. [PMID: 35096682 DOI: 10.18683/germs.2021.1300] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Imran M, Alshrari AS, Asdaq SMB, Abida. Trends in the development of remdesivir based inventions against COVID-19 and other disorders: A patent review. J Infect Public Health 2021;14:1075-86. [PMID: 34243049 DOI: 10.1016/j.jiph.2021.06.013] [Reference Citation Analysis]
18 Dörschug A, Frickmann H, Schwanbeck J, Yilmaz E, Mese K, Hahn A, Groß U, Zautner AE. Comparative Assessment of Sera from Individuals after S-Gene RNA-Based SARS-CoV-2 Vaccination with Spike-Protein-Based and Nucleocapsid-Based Serological Assays. Diagnostics (Basel) 2021;11:426. [PMID: 33802453 DOI: 10.3390/diagnostics11030426] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
19 Mendez-lizarraga CA, Chacon-cruz E, Carrillo-meza R, Hernández-milán NS, Inustroza-sánchez LC, Ovalle-marroquín DF, Machado-contreras JR, Ceballos Zuñiga O, Bejarano-ramírez V, Aguilar-aguayo C, Medina-amarillas A, Ceballos-liceaga SE, Zazueta OE. Report of Adverse Effects Following Population-Wide COVID-19 Vaccination: A Comparative Study between Six Different Vaccines in Baja-California, Mexico. Vaccines 2022;10:1196. [DOI: 10.3390/vaccines10081196] [Reference Citation Analysis]
20 de la Monte SM, Long C, Szczepanski N, Griffin C, Fitzgerald A, Chapin K. Heterogeneous Longitudinal Antibody Responses to Covid-19 mRNA Vaccination. Clin Pathol 2021;14:2632010X211049255. [PMID: 34647020 DOI: 10.1177/2632010X211049255] [Reference Citation Analysis]
21 Sanyaolu A, Marinkovic A, Prakash S, Abbasi AF, Patidar R, Williams M, Zhao A, Dzando G, Okorie C, Izurieta R. A Look at COVID-19 Global Health Situation, 1-Year Post Declaration of the Pandemic. Microbiol�Insights 2022;15:117863612210897. [DOI: 10.1177/11786361221089736] [Reference Citation Analysis]
22 Mitrović Dankulov M, Tadić B, Melnik R. Analysis of Worldwide Time-Series Data Reveals Some Universal Patterns of Evolution of the SARS-CoV-2 Pandemic. Front Phys 2022;10:936618. [DOI: 10.3389/fphy.2022.936618] [Reference Citation Analysis]
23 Rahmani R, Eivazi N, Paknejad M, Aminian M. A theoretical strategy for acceleration of human immune response against SARS-CoV-2: a fusion protein harboring virus-binding and pre-exposed antigen domains. Virusdisease 2021;:1-4. [PMID: 34277894 DOI: 10.1007/s13337-021-00704-4] [Reference Citation Analysis]
24 Rivero-Segura NA, Gomez-Verjan JC. In Silico Screening of Natural Products Isolated from Mexican Herbal Medicines against COVID-19. Biomolecules 2021;11:216. [PMID: 33557097 DOI: 10.3390/biom11020216] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
25 Alsaad HA, Almahdi JS, Alsalameen NA, Alomar FA, Islam MA. Assessment of self-medication practice and the potential to use a mobile app to ensure safe and effective self-medication among the public in Saudi Arabia. Saudi Pharmaceutical Journal 2022. [DOI: 10.1016/j.jsps.2022.05.010] [Reference Citation Analysis]
26 Prakash S. Development of COVID 19 vaccine: A summarized review on global trials, efficacy, and effectiveness on variants. Diabetes Metab Syndr 2022;16:102482. [PMID: 35427915 DOI: 10.1016/j.dsx.2022.102482] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Khattab AR, Teleb M, Kamel MS. In silico study of potential anti-SARS cell entry phytoligands from Phlomis aurea: a promising avenue for prophylaxis. Future Virol 2021;0. [PMID: 34745316 DOI: 10.2217/fvl-2021-0031] [Reference Citation Analysis]
28 Negrini TC, Carlos IZ, Duque C, Caiaffa KS, Arthur RA. Interplay Among the Oral Microbiome, Oral Cavity Conditions, the Host Immune Response, Diabetes Mellitus, and Its Associated-Risk Factors-An Overview. Front Oral Health 2021;2:697428. [PMID: 35048037 DOI: 10.3389/froh.2021.697428] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Kim YY, Sagara K, Uezu K. Functional Microfiber Nonwoven Fabric with Sialic Acid-Immobilized Polymer Brush for Capturing Lectin in Aerosol. Polymers (Basel) 2022;14:663. [PMID: 35215575 DOI: 10.3390/polym14040663] [Reference Citation Analysis]
30 Chiu L, Shen M, Lo CH, Chiu N, Chen A, Shin HJ, Prsic EH, Hur C, Chow R, Lebwohl B. Effect of famotidine on hospitalized patients with COVID-19: A systematic review and meta-analysis. PLoS One 2021;16:e0259514. [PMID: 34735523 DOI: 10.1371/journal.pone.0259514] [Reference Citation Analysis]
31 Zheng J, Miao J, Guo R, Guo J, Fan Z, Kong X, Gao R, Yang L. Mechanism of COVID-19 Causing ARDS: Exploring the Possibility of Preventing and Treating SARS-CoV-2. Front Cell Infect Microbiol 2022;12:931061. [DOI: 10.3389/fcimb.2022.931061] [Reference Citation Analysis]
32 Zaki MEA, Al-Hussain SA, Masand VH, Sabnani MK, Samad A. Mechanistic and Predictive QSAR Analysis of Diverse Molecules to Capture Salient and Hidden Pharmacophores for Anti-Thrombotic Activity. Int J Mol Sci 2021;22:8352. [PMID: 34361118 DOI: 10.3390/ijms22158352] [Reference Citation Analysis]
33 Magro C, Crowson AN, Franks L, Schaffer PR, Whelan P, Nuovo G. The histologic and molecular correlates of COVID-19 vaccine-induced changes in the skin. Clinics in Dermatology 2021;39:966-84. [DOI: 10.1016/j.clindermatol.2021.07.011] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
34 Gusev E, Sarapultsev A, Solomatina L, Chereshnev V. SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19. Int J Mol Sci 2022;23:1716. [PMID: 35163638 DOI: 10.3390/ijms23031716] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
35 Chen S, Wang X, Ha D, Yoshitake R. White Button Mushroom (Agaricus bisporus) Interrupts Tissue AR-TMPRSS2 Expression and Attenuates Pro-inflammatory Cytokines in C57BL/6 Mice: Implication for COVID-19 Dietary Intervention. Res Sq 2021:rs. [PMID: 33791688 DOI: 10.21203/rs.3.rs-244245/v1] [Reference Citation Analysis]
36 Thomas K, Ocran C, Monterastelli A, Sadun AA, Cockerham KP. Bridging the Gap between Ophthalmology and Emergency Medicine in Community-Based Emergency Departments (EDs): A Neuro-Ophthalmology Guide for ED Practitioners. Clin Pract 2021;11:919-32. [PMID: 34940005 DOI: 10.3390/clinpract11040106] [Reference Citation Analysis]
37 McLaughlin KM, Bojkova D, Kandler JD, Bechtel M, Reus P, Le T, Rothweiler F, Wagner JUG, Weigert A, Ciesek S, Wass MN, Michaelis M, Cinatl J Jr. A Potential Role of the CD47/SIRPalpha Axis in COVID-19 Pathogenesis. Curr Issues Mol Biol 2021;43:1212-25. [PMID: 34698067 DOI: 10.3390/cimb43030086] [Reference Citation Analysis]
38 Mahgoub IM, Abdelrahman A, Abdallah TA, Mohamed Ahmed KAH, Omer MEA, Abdelrahman E, Salih ZMA. Psychological effects of the COVID-19 pandemic: Perceived stress, anxiety, work-family imbalance, and coping strategies among healthcare professionals in Khartoum state hospitals, Sudan, 2021. Brain Behav 2021. [PMID: 34333876 DOI: 10.1002/brb3.2318] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
39 Dos Santos PK, Sigoli E, Bragança LJG, Cornachione AS. The Musculoskeletal Involvement After Mild to Moderate COVID-19 Infection. Front Physiol 2022;13:813924. [PMID: 35492595 DOI: 10.3389/fphys.2022.813924] [Reference Citation Analysis]
40 Bonomo MG, Giura T, Salzano G, Longo P, Mariconda A, Catalano A, Iacopetta D, Ceramella J, Sinicropi MS, Saturnino C. Bis-Thiourea Quaternary Ammonium Salts as Potential Agents against Bacterial Strains from Food and Environmental Matrices. Antibiotics (Basel) 2021;10:1466. [PMID: 34943678 DOI: 10.3390/antibiotics10121466] [Reference Citation Analysis]
41 Uysal EB, Gümüş S, Bektöre B, Bozkurt H, Gözalan A. Evaluation of antibody response after COVID-19 vaccination of healthcare workers. J Med Virol 2021. [PMID: 34704620 DOI: 10.1002/jmv.27420] [Reference Citation Analysis]
42 Tang M, Cheng L, Liu Y, Wu Z, Zhang X, Luo S. Plant Polysaccharides Modulate Immune Function via the Gut Microbiome and May Have Potential in COVID-19 Therapy. Molecules 2022;27:2773. [PMID: 35566123 DOI: 10.3390/molecules27092773] [Reference Citation Analysis]
43 Xiang Q, Cheng L, Zhang R, Liu Y, Wu Z, Zhang X. Tea Polyphenols Prevent and Intervene in COVID-19 through Intestinal Microbiota. Foods 2022;11:506. [DOI: 10.3390/foods11040506] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Panchal D, Kataria J, Patel K, Crowe K, Pai V, Azizogli AR, Kadian N, Sanyal S, Roy A, Dodd-O J, Acevedo-Jake AM, Kumar VA. Peptide-Based Inhibitors for SARS-CoV-2 and SARS-CoV. Adv Ther (Weinh) 2021;:2100104. [PMID: 34514085 DOI: 10.1002/adtp.202100104] [Reference Citation Analysis]
45 Fusco A, Padua L, Coraci D, Loreti C, Castelli L, Costantino C, Frizziero A, Serafini E, Biscotti L, Bernabei R, Giovannini S. Developing Pulmonary Rehabilitation for COVID-19: Are We Linked with the Present Literature? A Lexical and Geographical Evaluation Study Based on the Graph Theory. J Clin Med 2021;10:5763. [PMID: 34945063 DOI: 10.3390/jcm10245763] [Reference Citation Analysis]
46 Fu Y, Ho W, Kang N, Tsai M, Wu J, Huang L, Weng C. Pharmaceutical Prospects of Curcuminoids for the Remedy of COVID-19: Truth or Myth. Front Pharmacol 2022;13:863082. [DOI: 10.3389/fphar.2022.863082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Enayathullah MG, Parekh Y, Banu S, Ram S, Nagaraj R, Kumar BK, Idris MM. Gramicidin S and melittin: potential anti-viral therapeutic peptides to treat SARS-CoV-2 infection. Sci Rep 2022;12:3446. [PMID: 35236909 DOI: 10.1038/s41598-022-07341-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
48 Philips CA, Kakkar K, Joseph M, Yerol PK, Ahamed R, Rajesh S, Augustine P. Critically Ill COVID-19 Patient with Chronic Liver Disease - Insights into a Comprehensive Liver Intensive Care. J Clin Transl Hepatol 2021;9:576-86. [PMID: 34447688 DOI: 10.14218/JCTH.2020.00110] [Reference Citation Analysis]
49 Bojkova D, Costa R, Reus P, Bechtel M, Jaboreck MC, Olmer R, Martin U, Ciesek S, Michaelis M, Cinatl J Jr. Targeting the Pentose Phosphate Pathway for SARS-CoV-2 Therapy. Metabolites 2021;11:699. [PMID: 34677415 DOI: 10.3390/metabo11100699] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Zaki MEA, Al-Hussain SA, Masand VH, Akasapu S, Bajaj SO, El-Sayed NNE, Ghosh A, Lewaa I. Identification of Anti-SARS-CoV-2 Compounds from Food Using QSAR-Based Virtual Screening, Molecular Docking, and Molecular Dynamics Simulation Analysis. Pharmaceuticals (Basel) 2021;14:357. [PMID: 33924395 DOI: 10.3390/ph14040357] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Rao SJA, Shetty NP. Structure-based screening of natural product libraries in search of potential antiviral drug-leads as first-line treatment to COVID-19 infection. Microb Pathog 2022;165:105497. [PMID: 35337962 DOI: 10.1016/j.micpath.2022.105497] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Urbán P, Italiani P, Boraschi D, Gioria S. The SARS-CoV-2 Nucleoprotein Induces Innate Memory in Human Monocytes. Front Immunol 2022;13:963627. [DOI: 10.3389/fimmu.2022.963627] [Reference Citation Analysis]
53 Brogna B, Bignardi E, Brogna C, Capasso C, Gagliardi G, Martino A, Musto LA. COVID-19 Pneumonia in Vaccinated Population: A Six Clinical and Radiological Case Series. Medicina (Kaunas) 2021;57:891. [PMID: 34577814 DOI: 10.3390/medicina57090891] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Polis MA. Reassessing the Association of Vitamin D Level With SARS-CoV-2 Seropositivity. JAMA Netw Open 2021;4:e2111750. [PMID: 34009353 DOI: 10.1001/jamanetworkopen.2021.11750] [Reference Citation Analysis]
55 Tammaro A, Adebanjo GAR, Parisella FR, De Marco G, Rello J. Local reactions to the second dose of the BNT162 COVID-19 vaccine. Dermatol Ther 2021;34:e15000. [PMID: 34031953 DOI: 10.1111/dth.15000] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
56 Giri S, Sen S, Singh R, Paul P, Sahu R, Nandi G, Dua TK. Current challenges in different approaches to control COVID-19: a comprehensive review. Bull Natl Res Cent 2022;46. [DOI: 10.1186/s42269-022-00730-2] [Reference Citation Analysis]
57 Meidaninikjeh S, Sabouni N, Taheri M, Borjkhani M, Bengar S, Majidi Zolbanin N, Khalili A, Jafari R. SARS-CoV-2 and Guillain-Barré Syndrome: Lessons from Viral Infections. Viral Immunol 2022. [PMID: 35766944 DOI: 10.1089/vim.2021.0187] [Reference Citation Analysis]
58 Ghzaiel I, Sassi K, Zarrouk A, Nury T, Ksila M, Leoni V, Bouhaouala-Zahar B, Hammami S, Hammami M, Mackrill JJ, Samadi M, Ghrairi T, Vejux A, Lizard G. 7-Ketocholesterol: Effects on viral infections and hypothetical contribution in COVID-19. J Steroid Biochem Mol Biol 2021;212:105939. [PMID: 34118414 DOI: 10.1016/j.jsbmb.2021.105939] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]